Myeloperoxidase G-463a Polymorphism And Coronary Artery Disease Susceptibility In The Chinese Population: An Updated Meta-Analysis And Review

Jin-Xia Zhang,Bing-Ling Li,Zhong-Qiu Lin,Ni Zhang,Xiong Peng,Zhi-Hua Gong,Liu-Cheng Long,Xuan Zhou,Ding-Cheng Xiang

2016-01-01

Abstract:Objective: Although a number of studies have been conducted on the association between myeloperoxidase (MPO) G-463A polymorphism and coronary artery disease (CAD), this association remains elusive and controversial. To assess the effects of MPO G-463A polymorphism on the risk of CAD in the Chinese population, an updated meta-analysis was performed. Methods: Related studies were identified from PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biology Medicine (CBM) up to 28th March 2015. Pooled ORs and 95% CIs were used to assess the strength of the associations. Results: A total of ten studies including 1808 CAD cases and 1030 controls were involved in this meta-analysis. In overall analysis, MPO -436 A variant genotype reduces the risk of CAD in the Chinese population (A vs. G: OR = 0.53, 95% CI = 0.43-0.66; AA vs. GG: OR = 0.25, 95% CI = 0.15-0.40; AA vs. GA: OR = 0.45, 95% CI = 0.33-0.62; AA and GA combined vs. GG: OR = 0.51, 95% CI = 0.40-0.66; AA vs. GA and GG: OR = 0.34, 95% CI = 0.25-0.46). In subgroups stratified by geographical location and source of controls, significant associations were found in North China, in South China, in hospital-based studies and population-based studies. Conclusions: This meta-analysis showed that the MPO G-463A variants may influence CAD risk in Chinese. Studies with larger sample sizes and wider spectrum of populations are warranted to verify this finding.